U.S. Food and Drug Administration Commissioner Marty Makary, under pressure, defends himself in an interview with CNBC's ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

Treatments for COVID-19, gout, nicotine dependence, severe hypertriglyceridemia, and thyroid eye disease are under review.

The FDA has approved zenocutuzumab-zbco as the first drug for certain patients with a rare and aggressive bile duct cancer.

May 8 (Reuters) - The U.S. Food and Drug Administration has approved Partner Therapeutics' drug for adults with a rare form ...

The FDA approved expanded use of Auvelity, an extended release major depressive disorder drug, for use in the treatment of Alzheimer disease.

This biotech company develops therapies for neurodegenerative and rare diseases, supported by clinical assets and pharma ...

There’s a new Medicare option for weight loss drugs. Here’s what older Americans should know about the program.

More than a decade ago, Yale chemist Craig Crews founded a biotechnology company in New Haven based on his pioneering ...

US regulators have withdrawn their approval of a GSK Plc drug that the Trump administration had promoted as a treatment for autism, adding another twist to the unusual story of a decades-old drug.

The US Food and Drug Administration (FDA) based its approvals for most novel drugs on single studies during 2022, according to findings from a cross-sectional analysis published as a research letter ...